Beatriz Carminati dos Santos

Beatriz Carminati dos Santos

Auto-generated profile, based on publicly available information

Beatriz Carminati dos Santos

Universidade Federal de Santa Catarina

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2026 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
NSNaiara de Souza Santos
Naiara de Souza Santos
IFIzabel Feltrin Fabro
Izabel Feltrin Fabro
BSBeatriz Carminati dos Santos
Beatriz Carminati dos Santos
DPDébOra Maria Russiano Pereira
DébOra Maria Russiano Pereira
Aderbal S Aguiar JrAderbal S Aguiar Jr
Aderbal S Aguiar Jr
Caffeine is a widely consumed ergogenic aid and a nonselective antagonist of adenosine receptors, including the facilitatory A2A subtype (A2AR), yet the magnitude of its performance-enhancing effect in rodents has not been formally quantified. We conducted a systematic review and meta-analysis of rodent studies administering caffeine before exercise, with risk of bias assessed using the SYRCLE tool (PROSPERO CRD420250653223). Fourteen studies met the eligibility criteria. Six studies of a single systemic dose preceding an aerobic task, comprising 71 animals were pooled using a restricted maximum likelihood random-effects model with a Hartung–Knapp interval, yielding a large ergogenic estimate with wide uncertainty (Hedges’ g = +1.31; 95% CI + 0.29 to +2.32; I2 = 71%). Prespecified rules, applied independently of the observed effects, precluded pooling of the two anaerobic studies, which measured different performance constructs, and of the three chronic-exposure studies, whose dosing regimens and exercise modalities were not comparable; these are reported descriptively, as are the intracerebral administration experiments. Risk of bias was frequently unclear or high in the randomization and blinding domains. Receptor-level evidence is reported separately as a narrative synthesis, because the search was not constructed to retrieve mechanistic studies: the ergogenic response was abolished in global and forebrain A2AR-knockout mice and reproduced by the selective antagonist SCH 58261, whereas A2AR agonism with NECA was ergolytic and reversed by caffeine, and deletion of CD73, which depletes the extracellular adenosine pool preferentially supplying A2AR, recapitulated the ergogenic phenotype. The rodent evidence provides preclinical support for A2AR involvement in exercise-induced fatigue on an evidence base too small and too heterogeneous to support therapeutic or performance translation.

8 September 2026 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
NSNaiara de Souza Santos
Naiara de Souza Santos
IFIzabel Feltrin Fabro
Izabel Feltrin Fabro
AAAna Paula Pinto de AraújO
Ana Paula Pinto de AraújO
BSBeatriz Carminati dos Santos
Beatriz Carminati dos Santos
TNTatyana Nery
Tatyana Nery
Aderbal S Aguiar JrAderbal S Aguiar Jr
Aderbal S Aguiar Jr
Adenosine triphosphate (ATP) signaling through the P2X7 receptor is an emerging determinant of mitochondrial energy metabolism and physical fitness, and the receptor is increasingly targeted pharmacologically for its role in inflammation. Whether systemic P2X7 antagonism affects aerobic capacity and the structural adaptation of the heart to exercise is unknown. Adult male Swiss mice were studied in a 2 × 2 factorial design crossing physical conditioning (sedentary or exercised) with treatment (saline or the P2X7 antagonist Brilliant Blue G, BBG; 50 mg/kg). Exercised animals trained on a treadmill on alternate days over approximately 4 weeks; maximal oxygen uptake (V̇O2max) and power were measured by incremental treadmill ergospirometry, and myocardial cardiomyocyte volume density (Vv) was quantified by design-based stereology. Aerobic training increased V̇O2max and cardiomyocyte Vv. BBG reduced V̇O2max and peak power independently of training and produced a deficit that widened progressively with workload across the incremental test, indicating a demand-dependent limitation of oxidative performance. Critically, BBG did not detectably alter the exercise-induced increase in cardiomyocyte Vv and showed no interaction with training; motor coordination, locomotor and exploratory behavior, blood lactate, and body mass were also unaffected. P2X7 antagonism thus impairs aerobic capacity without detectable blunting of the structural response of the heart to exercise. This functional–structural dissociation points to a metabolic process, plausibly mitochondrial, rather than to cardiac remodeling, although the present sample size bounds rather than excludes an effect on cardiac adaptation, and indicates that P2X7-directed therapies may reduce exercise capacity without producing overt cardiac structural change.

24 October 2026 in RECIMA21 - Revista Científica Multidisciplinar
Verified
Journal Article
Open access
FCFranciely Vanessa Costa
Franciely Vanessa Costa
BSBeatriz Carminati dos Santos
Beatriz Carminati dos Santos
FCFrancine Ceratti
Francine Ceratti
GAGiovana Granata Astolfi
Giovana Granata Astolfi
MZMarina Ilha Zimmermann
Marina Ilha Zimmermann
DSDiego dos Santos
Diego dos Santos
Objetivo: O objetivo do estudo consiste em rastrear indivíduos e estratificar o risco de desenvolvimento de diabetes mellitus tipo 2 utilizando o FINDRISC em Balneário Arroio do Silva, Santa Catarina. Métodos: Trata-se de um estudo transversal, de natureza analítica e descritiva, cuja coleta de dados foi realizada no município de Balneário Arroio do Silva, junho de 2024 a maio de 2025. Um instrumento de rastreamento e estratificação de risco finlandês (FINDRISC) foi utilizado na pesquisa, além da coleta de medidas antropométricas e de glicemia capilar dos participantes. A seleção dos participantes ocorreu por conveniência em unidades básicas de saúde. Resultados: A amostra resultou em 382 participantes, atendendo ao cálculo amostral. Na avaliação executada observou-se que apenas 16,49% dos participantes obtiveram um escore considerado baixo, enquanto os demais participantes tiveram distribuição de risco discretamente elevado em 27,23%, moderado em 23,56%, alto em 25,65% e muito alto em 7,07%, com o sexo feminino possuindo pontuação mais elevada de risco. Conclusão: A amostra apresentou elevada proporção de participantes classificados nas categorias de risco alto e muito alto para desenvolvimento de diabetes mellitus tipo 2, conforme os critérios do FINDRISC.

1 October 2024 in RECIMA21 - Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
FCFranciely Vanessa Costa
Franciely Vanessa Costa
BSBeatriz Carminati dos Santos
Beatriz Carminati dos Santos
FCFrancine Ceratti
Francine Ceratti
GAGiovana Granata Astolfi
Giovana Granata Astolfi
MZMarina Ilha Zimmermann
Marina Ilha Zimmermann
YRYasmin Guimarães Rodrigues
Yasmin Guimarães Rodrigues
O diabetes mellitus é uma condição crônica que vem crescendo nos últimos anos, principalmente nos países em desenvolvimento. Alguns fatores contribuem para este cenário como o sedentarismo, sobrepeso e obesidade, maior urbanização e envelhecimento populacional. O Escore Finlandês de Risco de Diabetes (FINDRISC) é uma ferramenta que avalia alguns fatores como idade, índice de massa corporal, circunferência da cintura, prática de atividades físicas, alimentação, uso de anti-hipertensivos, resultados de glicemia elevada e se tem casos de diabetes na família. A ferramenta tem potencial para ser usado como rastreamento em diferentes cenários brasileiros. Trata-se de um estudo descritivo, tipo relato de experiência, elaborado no contexto do projeto de extensão Novembro Azul Diabetes. Nos dias 09, 16 e 23 de novembro de 2023, foram realizadas as ações do projeto na comunidade universitária UFSC Araranguá. Um espaço no hall de entrada do campus foi preparado e identificado com banner. Foram atendidas 125 pessoas entre estudantes, servidores e terceirizados e o projeto teve boa receptividade. A execução do projeto atingiu os objetivos iniciais de rastreamento e avaliação da predisposição a desenvolver a doença. A universidade cumpre seu papel de educar e conscientizar sobre os fatores de risco para o desenvolvimento do Diabetes.

29 September 2026 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
BSBeatriz Carminati dos Santos
Beatriz Carminati dos Santos
IRIzabely Guedes da Rosa
Izabely Guedes da Rosa
LMLaízE de Freitas Mazzardo
LaízE de Freitas Mazzardo
NSNaiara de Souza Santos
Naiara de Souza Santos
IFIzabel Feltrin Fabro
Izabel Feltrin Fabro
Aderbal S Aguiar JrAderbal S Aguiar Jr
Aderbal S Aguiar Jr
Motor impairment in parkinsonism extends beyond the classical triad to weakness and a reduced capacity to sustain motor output, whose neuromodulatory control is poorly resolved. The endocannabinoid system is a candidate regulator, but CB1 and CB2 receptors have not been separated within one preparation. Reserpine-treated adult female Swiss mice received vehicle, the CB1 antagonist AM251, or the CB2 antagonist AM630 into the lateral ventricle; catalepsy was recorded across three trials and neuromuscular performance in a grip force task. Both antagonists increased the force generated at task onset, by amounts these data cannot distinguish: AM630 by 53.9 gf (95% CI 22.5–85.3) and AM251 by 41.2 gf (95% CI 8.8–73.6). They separated on duration. AM251 increased grip time by 619 ms (95% CI 113–1125), whereas AM630 did not (−70 ms, 95% CI −560 to +421). An interaction contrast on the force–time balance followed from that difference: AM630 shifted the balance toward force (−2.03 SD, P = 0.008), AM251 did not (−0.36 SD, P = 0.66), and the two differed from each other by 1.67 SD (P = 0.022). AM251 also reduced the odds of a cataleptic response (OR 0.16, 95% CI 0.03–0.89). Adjusting for body mass left both force effects unchanged. The dissociation is therefore in the duration of effort rather than in its force: both antagonists raise force, and only CB1 blockade also extends the time over which it is maintained. Delivered intracerebroventricularly, these effects are central in origin but not anatomically localized.